His points about CC being another bovine pericardium path is something I've thought myself. Also, the 7 year study everyone is mentioning? It is indeed a small sample size but a seemingly good preliminary study of clinical outcomes.
Most of the statements on both ends are just too extreme. I think CC has a bright future and looks like it'll take off. Good stuff.
Nice volume, page-159
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.82 |
Change
-1.230(7.21%) |
Mkt cap ! $306.5M | |||
| Open | High | Low | Value | Volume |
| $16.50 | $16.50 | $15.80 | $305.6K | 18.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1317 | $15.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.99 | 205 | 3 |
View Market Depth
| Last trade - 11.59am 24/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |